Clinical efficacy and safety of brinzolamide (Azopt™), a new topical carbonic anhydrase inhibitor for primary open-angle glaucoma and ocular hypertension
- 30 September 1998
- journal article
- clinical trial
- Published by Elsevier in American Journal of Ophthalmology
- Vol. 126 (3) , 400-408
- https://doi.org/10.1016/s0002-9394(98)00095-6
Abstract
No abstract availableKeywords
This publication has 3 references indexed in Scilit:
- A Six-week Dose-response Study of the Ocular Hypotensive Effect of Dorzolamide With a One-year ExtensionAmerican Journal of Ophthalmology, 1996
- Patient Tolerance to Carbonic Anhydrase InhibitorsAmerican Journal of Ophthalmology, 1978
- Carbonic Anhydrase Inhibitor Side EffectsArchives of Ophthalmology (1950), 1977